opc 3911 has been researched along with isoproterenol in 5 studies
| Studies (opc 3911) | Trials (opc 3911) | Recent Studies (post-2010) (opc 3911) | Studies (isoproterenol) | Trials (isoproterenol) | Recent Studies (post-2010) (isoproterenol) |
|---|---|---|---|---|---|
| 16 | 0 | 0 | 30,780 | 803 | 2,640 |
| Protein | Taxonomy | opc 3911 (IC50) | isoproterenol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 0.246 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.333 | |
| Beta-2 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2125 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 1.77 | |
| Beta-1 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2125 | |
| Beta-3 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2125 | |
| Beta-2 adrenergic receptor | Canis lupus familiaris (dog) | 0.6667 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, TL; Vinge, E | 1 |
| Andersson, KE; Lindgren, S | 1 |
| Andersson, KE; Andersson, TL; Lindgren, SH; Vinge, E | 1 |
| Andersson, KE; Belfrage, P; Degerman, E; Lindgren, S; Manganiello, VC | 1 |
| Abzhalelov, BB; Bronnikov, GE; Dolgacheva, LP; Zhang, SJ; Zinchenko, VP | 1 |
5 other study(ies) available for opc 3911 and isoproterenol
| Article | Year |
|---|---|
Interactions between isoprenaline, sodium nitroprusside, and isozyme-selective phosphodiesterase inhibitors on ADP-induced aggregation and cyclic nucleotide levels in human platelets.
Topics: Cyclic AMP; Cyclic GMP; Drug Interactions; Humans; Isoproterenol; Nitroprusside; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinones; Quinolones | 1991 |
Comparison of the effects of milrinone and OPC 3911 with those of isoprenaline, forskolin and dibutyryl-cAMP in rat aorta.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta, Thoracic; Bucladesine; Calcium; Colforsin; In Vitro Techniques; Isoproterenol; Male; Milrinone; Phenylephrine; Phosphodiesterase Inhibitors; Potassium; Pyridones; Quinolones; Rats; Rats, Inbred Strains; Vasodilation | 1991 |
Effects of isozyme-selective phosphodiesterase inhibitors on rat aorta and human platelets: smooth muscle tone, platelet aggregation and cAMP levels.
Topics: Animals; Blood Platelets; Cyclic AMP; Guanfacine; Humans; In Vitro Techniques; Isoenzymes; Isoproterenol; Male; Milrinone; Muscle Tonus; Muscle, Smooth; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridones; Quinolones; Rats; Rats, Inbred Strains; Vinca Alkaloids | 1990 |
Relaxant effects of the selective phosphodiesterase inhibitors milrinone and OPC 3911 on isolated human mesenteric vessels.
Topics: Adult; Aged; Calcium Channel Blockers; Colforsin; Female; Humans; In Vitro Techniques; Isoproterenol; Male; Middle Aged; Milrinone; Muscle, Smooth, Vascular; Norepinephrine; Ouabain; Phosphodiesterase Inhibitors; Potassium; Pyridones; Quinolones; Splanchnic Circulation; Vasodilator Agents | 1989 |
Norepinephrine induces slow calcium signalling in murine brown preadipocytes through the beta-adrenoceptor/cAMP/protein kinase A pathway.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adipocytes; Adipose Tissue, Brown; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Calcium Signaling; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Isoproterenol; Isoquinolines; Male; Mice; Mice, Inbred Strains; Norepinephrine; Phosphodiesterase Inhibitors; Quinolones; Receptors, Adrenergic, beta; Sulfonamides; Thapsigargin | 2003 |